| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 07/24/2008 | US20080176825 Oral Neurotherapeutic Cefazolin Compositons |
| 07/24/2008 | US20080176807 Facially amphiphilic polymers and oligomers and uses thereof |
| 07/24/2008 | US20080176323 Expression vector comprising nucleotide sequences coding cytokine polypeptide for use in treatment and prevention of lung, viral, cell proliferative and inflammatory diseases |
| 07/24/2008 | US20080175932 Method for Decreasing Nicotine and Other Substance Use in Humans |
| 07/23/2008 | EP1671949B1 Substituted Pyridinylamines |
| 07/23/2008 | EP1608962A4 Model for neurodegenerative disorders |
| 07/23/2008 | EP1080092B1 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
| 07/23/2008 | CN100403900C Mitotic kinesin inhibitors |
| 07/22/2008 | US7402581 3,5-Dibromo-N-[(2S)-2-(4-fluorophenyl)-4-(3-morpholin-4-ylazetidin-1-yl)butyl]-N-methylbenzamide; neurokinin 1 and 2 (NK1,2) receptors, antagonist; improved pharmacokinetics: not inhibit liver enzyme cytochrome P450, prevent drug-drug interactions, oral bioavailability, antiinflammatory and analgesic |
| 07/22/2008 | US7402559 Composition and method of treatment for urogenital conditions |
| 07/22/2008 | US7402324 Process for preparing aqueous extracts of plants and extracts so obtained |
| 07/22/2008 | US7402180 Composition for the oxidation dyeing of keratin fibres, comprising at least one fatty alcohol chosen from mono- and polyglycerolated fatty alcohols and a particular polyol |
| 07/17/2008 | US20080171758 Compounds and methods for the treatment of cancer |
| 07/17/2008 | US20080171106 Exposing probiotic to a gastric juice; providing a model of a pet small intestine;introducing the probiotic and a pathogen into the model;measuring anti-pathogenic metabolite produced by probiotic; andusing the identified probiotic to produce a pet food |
| 07/17/2008 | US20080171096 Method for Decreasing Nicotine and Other Substance Use in Humans |
| 07/17/2008 | US20080171058 Compositions and Methods For Synergistic Induction of Antitumor Immunity |
| 07/16/2008 | EP1944607A2 Toluidine blue O compounds and their manufacture, analysis and use |
| 07/16/2008 | EP1944322A2 Treatment of TNF alpha related disorders |
| 07/16/2008 | EP1944320A1 Immunoglobulin variants and uses thereof |
| 07/16/2008 | EP1648377A4 Method of treating diabetes type ii |
| 07/16/2008 | EP1476541B1 Cytokine (zcytor17 ligand) |
| 07/16/2008 | EP1200108B1 Use of ginkgo extract for treating cancer which is characterized by an over-expression of peripheral-type benzodiazepine receptor protein |
| 07/16/2008 | EP1165551B1 C10 carbamoyloxy substituted taxanes as antitumor agents |
| 07/16/2008 | CN101219204A Combinations comprising a low molecular weight thrombin inhibitor and a prodrug of a low molecular weight thrombin inhibitor |
| 07/16/2008 | CN100402499C 2-iminopyrrolidine derivatives |
| 07/15/2008 | US7399866 2-(Imidazol-1-ylalkyl)-3H-quinazolin-4-one derivatives; mitotic kinesin KSP inhibitors; anticarcinogenic, antiinflammatory, and antiproliferative agents |
| 07/15/2008 | US7399821 Alkylated poly(allylamine) polymers and methods of use |
| 07/15/2008 | US7399779 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives useful as muscarinic receptor antagonists |
| 07/15/2008 | US7399763 and highly specific HIV replication inhibitor; ethyl 2-benzyl-8-hydroxy-1-oxo-1,2,3,4-tetrahydropyrrolo[1,2- alpha ]pyrazine-7-carboxylate; aquired immune deficiency syndrome (AIDS) |
| 07/15/2008 | US7399630 Cell culture vessel having a polymer surface, a cell adhesion resistant material (CAR) bonded to the polymer (e.g., hyaluronic acid), and one or more peptides covalently bound to the CAR material that promote adherence of cells that do not adhere to the CAR layer in the absence of the peptides |
| 07/15/2008 | US7399474 Administering to a vertebrate an amount of a polynucleotide operatively encoding at least an immunogenic portion of the csa operon and having at least about 15 nucleotides; for prevention of enterotoxigenic e. coli colonization (diarrhea) |
| 07/15/2008 | US7399472 Vaccines |
| 07/15/2008 | CA2378892C Preserved pharmaceutical formulations |
| 07/15/2008 | CA2362271C Essential fatty acids in the prevention of cardiovascular events |
| 07/15/2008 | CA2290615C Desensitizing dentifrice having limited astringency |
| 07/10/2008 | US20080167471 comprising 4-[4-[4-(Hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]- alpha , alpha -dimethylbenzeneacetic acid hydrochloride; antiallergic agents and bronchodilators |
| 07/10/2008 | US20080167469 Preparing anhydrous 4-(4-(4-(Hydroxydiphenylmethyl)-1-piperidinyl)-1-hydroxybutyl)-alpha,alpha -dimethylbenzene acetic acid hydrochloride by azeotropic distillation of the corresponding hydrate |
| 07/10/2008 | US20080167458 Nucleotide sequences coding immunoglobulin specific to cell surface transmembrane receptor for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 07/10/2008 | US20080167300 N-(Arylidene)morpholinylpyridinylhydrazine derivatives, e.g., N-{4-[2-(3,4-Dimethoxy-phenyl)-ethoxy]-6-morpholin-4-yl-pyridin-2-yl}-N'-(3-methyl-benzylidene)-hydrazine, are used for treating interleukin-12 overproduction-related disorders including inflammatory diseases |
| 07/10/2008 | US20080166405 Abuse-resistant oral dosage forms and method of use thereof |
| 07/10/2008 | US20080166371 HPV31(human papillomavirus) virus-like particles (VLPs); vaccines and drugs for preventing hepatitis |
| 07/10/2008 | US20080166367 Custom Vectors for Treating and Preventing Pancreatic Cancer |
| 07/09/2008 | EP1941868A2 Improvements in or relating to the delivery of oral drugs |
| 07/09/2008 | EP1455756B1 Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist |
| 07/09/2008 | EP1220842B1 Cyclic amine compound as ccr5 antagonist |
| 07/09/2008 | CN101214249A Chaperone-based therapy for niemann-pick disease |
| 07/09/2008 | CN100400098C Medicine composition containing octreotide grains |
| 07/08/2008 | US7398279 Method, routines and system for identification of imprints on dosage forms |
| 07/08/2008 | US7396935 p38 kinase inhibitors; inflammatory bowel disease, rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease, and congestive heart failure |
| 07/08/2008 | US7396855 Foods; skin, lipid, liver, and cardiovascular disorders; hormone dependent diseases, osteopenia, osteoporosis,and acute ovarian estrogen deficiency; biosynthesis by metabolism of isoflavone; drug delivery |
| 07/08/2008 | US7396847 Oxazolidinone and/or isoxazoline as antibacterial agents |
| 07/08/2008 | US7396826 prophylaxis/therapy of diabetes, inflammation, cancer, necrosis, gastric ulcers, neurodegenerative and neuropathic diseases, neuropathic pain, polyneuropathy using e.g. Octadeca-6,9,12-trienoic acid 5' -(2,4-dioxo-3,4-dihydro-2H-pyrimidine-1-yl)-3',4 dihydroxy-tetrahydrofuran-2'-yl methyl ester |
| 07/08/2008 | US7396824 2-O sulfatase nucleic acid compositions |
| 07/08/2008 | US7396546 Anti-microbial compositions and methods of using same |
| 07/08/2008 | CA2432131C Pyrazole compounds useful as protein kinase inhibitors |
| 07/08/2008 | CA2383164C Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system |
| 07/08/2008 | CA2330719C Synergistic compositions comprising an ascorbate and lysine for states related to extra cellular matrix degeneration |
| 07/08/2008 | CA2317054C Preemptive prophylaxis of migraine device and method |
| 07/08/2008 | CA2285380C Solid compositions suitable for oral administration comprising non hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-amino-ethanesulfonic acid |
| 07/03/2008 | US20080161334 Macrolides |
| 07/03/2008 | US20080161250 Topical treatment or prevention of ocular infections |
| 07/03/2008 | US20080161241 Preventing sustained monomorphic ventricular tachycardia following myocardial ischemia by administering etanercept; or bortezomib; inhibits substantial loss of beta-adrenergic receptor kinase (beta-ARK) activity |
| 07/03/2008 | US20080161238 Nucleic acid molecules encoding bacterial autoinducer inactivation proteins as targets for engineering disease resistance |
| 07/03/2008 | US20080161234 Treating bacterial vaginosis and fungal infections such as yeast infections; use of antibiotics may be reduced; lactoferrin enhances antimicrobial effect of lactate |
| 07/03/2008 | US20080160018 Using mik- beta 1 monoclonal antibody as therapeutic tool in treatment and prevention of graft vs. host, autoimmune and diabetic disorders |
| 07/03/2008 | US20080159978 Using bioactive compounds to induce or accelerate healing of damaged skin |
| 07/03/2008 | US20080159957 administrating a non-pathogenic, insect-specific virus to induce an immune response, and effective to cause cell death in the cell; cancer vaccines and immunotherapies; immunostimulants, biodrugs |
| 07/02/2008 | EP1937363A2 Use of compounds comprising fatty acid entities |
| 07/02/2008 | EP1627076A4 Biological markers for diagnosing rheumatoid arthritis |
| 07/02/2008 | EP1587394A4 Oral-care device and system |
| 07/02/2008 | EP0969878B1 Method for detecting abnormal epithelial cell shedding |
| 07/02/2008 | CN100398519C Tetracyclic benzamide derivatives and methods of use thereof |
| 07/01/2008 | US7393959 Di-aryl substituted pyrrole modulators of metabotropic glutamate receptor-5 |
| 07/01/2008 | US7393874 Reacting tolterodine with tartaric acid in solvent; spray drying |
| 07/01/2008 | US7393846 phosphodiesterase type 4 inhibitors; N-(3,5-dichloropyrid-4-yl)-4-difluoromethoxy-8-methanesulfonamido-dibenzo[b,d]furan-1-carboxamide; antiinflammatory agent, antiallergen; asthma or chronic obstructive pulmonary disease |
| 07/01/2008 | US7393844 Tetrahydropyranyl cyclopentyl heterocyclic amide modulators of chemokine receptor activity |
| 07/01/2008 | US7393493 Curable mixture of a bone substitute, a dianhydride of a dicarboxylic acid and an unsaturated carboxylic acid (dimethacrylic anhydride of sebacic acid and/or 1,3-bis(p-carboxyphenoxy)propane), photoinitiator, and redox catalyst; dental, orthopedic and drug delivery applications |
| 06/26/2008 | US20080153891 Synergistic anti-cancer compositions |
| 06/26/2008 | US20080153864 Spiroazabicyclic Heterocyclic Compounds |
| 06/26/2008 | US20080153823 a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy |
| 06/25/2008 | EP1936376A2 Screening and treatment methods for prevention of preterm delivery |
| 06/25/2008 | EP1935421A1 Controlled-release compositions containing opioid agonist and antagonist |
| 06/25/2008 | EP1933861A1 Method for treating or preventing ischemia reperfusion injury or multi-organ failure |
| 06/25/2008 | EP1933807A1 Cosmetic product for the treatment of scalp |
| 06/25/2008 | EP1667730A4 Compositions and methods for treating inflammatory lung disease |
| 06/25/2008 | EP1606266A4 Chemical compounds |
| 06/25/2008 | CN100397082C HCV-free-blood external preparing method |
| 06/25/2008 | CN100396785C Resoldution method for racemic compound of nucleoside enantiomorph |
| 06/25/2008 | CN100396769C Novel probiotics for pet food applications |
| 06/25/2008 | CN100396680C Vla-4 inhibitors |
| 06/25/2008 | CN100396610C Method and device for silicon dioxide from rice husk ash |
| 06/25/2008 | CN100396276C Compositions containing organic compounds |
| 06/24/2008 | US7390810 Pyrazole-amine compounds useful as kinase inhibitors |
| 06/19/2008 | US20080146836 New Aminopropylphosphinic acids |
| 06/19/2008 | US20080146803 Antibiotics containing borinic acid complexes and methods of use |
| 06/19/2008 | US20080146778 Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same |
| 06/19/2008 | US20080146653 Synergistic anti-cancer compositions |
| 06/19/2008 | US20080146648 Less toxicity; side effects redution; administering substituted p-chlorobenzene and a pyrrolethoxybenzene |
| 06/19/2008 | US20080146529 Skin peeling composition and method |
| 06/19/2008 | US20080145449 Thiol reactive agents as a therapeutic modality |